Discuss This Disease

4 free views remaining today

X-linked dominant hypophosphatemic rickets

ICD-10 Codes

Related ICD-10:

Description

X-linked Dominant Hypophosphatemic Rickets (XLHRD)

X-linked dominant hypophosphatemic rickets (XLHRD) is a rare genetic disorder characterized by low levels of phosphate in the blood, termed hypophosphatemia. This condition is caused by mutations in the phosphate-regulating endopeptidase gene (PHEX; 300550) on chromosome Xp22.

Key Features:

  • Hypophosphatemia: Low levels of phosphate in the blood
  • Rickets and/or Osteomalacia: Softening of bones due to lack of mineralization
  • Diminished Growth: Impaired growth and development in affected individuals

Inheritance Pattern: XLHRD is inherited in an X-linked dominant pattern, meaning that a single copy of the mutated gene on the X chromosome is sufficient to cause the condition. This means that males are more frequently affected than females.

References:

  • [8] describes XLHRD as a hereditary renal phosphate-wasting disorder characterized by hypophosphatemia, rickets and/or osteomalacia, and diminished growth.
  • [5] states that X-linked hypophosphatemic rickets (XLH) is an X-linked dominant disorder characterized by hypophosphatemia, decreased reabsorption of phosphorus by the renal tubules, and impaired mineralization of bones.

Additional Characteristics

  • Low levels of phosphate in the blood
  • Softening of bones due to lack of mineralization
  • Impaired growth and development in affected individuals

Signs and Symptoms

Common Signs and Symptoms

X-linked dominant hypophosphatemic rickets, also known as XLH, is a genetic disorder that affects the body's ability to regulate phosphate levels. The symptoms of XLH can vary in severity and may include:

  • Short stature: Impaired growth and development are common in individuals with XLH [4].
  • Bone pain: Severe bone pain and tenderness at major joints are often the first signs of XLH [5].
  • Skeletal deformities: Bowed legs or knock knees, characteristic of rickets, can occur due to chronic hypophosphatemia [7].
  • Muscle weakness: Muscle weakness is a common symptom in individuals with XLH, particularly pronounced in nutritional rickets [8].
  • Dental abscesses: Dental problems, including abscesses and severe dental pain, are frequent in XLH patients [3].

Other Possible Symptoms

In addition to the above symptoms, individuals with XLH may also experience:

  • Impaired growth: Growth retardation is a common feature of XLH.
  • Increased tendency for fractures: The chronic hypophosphatemia associated with XLH can lead to an increased risk of fractures.
  • Muscle spasms: Muscle spasms and cramps are possible symptoms in individuals with XLH.

References

[1] Features include bowed or bent legs, short stature, bone pain, and severe dental pain. XLH is caused by genetic changes in the PHEX gene on the X chromosome, ...

[2] The most noticeable of these abnormalities are bowed legs or knock knees. These abnormalities become apparent with weight-bearing activities ...

[3] Other signs/symptoms include: impaired growth, bone tenderness, muscle weakness, dental abscesses, increased tendency for fractures, muscle spasms, wrist ...

[4] X-linked hypophosphatemia (XLH) manifests during childhood with typical clinical features of rickets such as short stature, bone pain, and skeletal deformities ...

[5] Bone pain, tenderness at major joints, or undiagnosed fractures incidentally found on x-ray are often the first symptoms or signs of XLH. Once ...

[6] The disease presents as a spectrum of abnormalities, from hypophosphatemia alone to growth retardation and short stature to severe rickets or osteomalacia.

[7] The chronic hypophosphatemia resulting from these impairments can lead to rickets, a childhood bone disease with characteristic bow deformities of the legs, ...

[8] by MD Ruppe · 2017 · Cited by 64 — Muscle weakness is often more pronounced in nutritional rickets. Dental abscesses, enthesopathy, and calcification of spinal ligaments appear to ...

Additional Symptoms

Diagnostic Tests

Diagnosing X-linked Dominant Hypophosphatemic Rickets

X-linked dominant hypophosphatemic rickets is a genetic disorder characterized by low levels of phosphate in the blood, leading to softening and weakening of bones. Diagnosing this condition involves a combination of clinical evaluation, biochemical analysis, and molecular genetic testing.

Clinical Evaluation The diagnosis of X-linked dominant hypophosphatemic rickets typically begins with a thorough clinical evaluation, including:

  • Assessing family history for similar conditions
  • Evaluating symptoms such as softening or weakening of bones, short stature, and delayed bone age
  • Conducting physical examination to look for signs of rickets or osteomalacia

Biochemical Analysis Biochemical analysis is essential in diagnosing X-linked dominant hypophosphatemic rickets. The following tests are typically performed:

  • Serum levels of calcium, phosphate, alkaline phosphatase, 1,25-dihydroxyvitamin D3, parathyroid hormone (PTH), and FGF-23
  • These tests help confirm the presence of hypophosphatemia and rule out other conditions that may cause similar symptoms

Molecular Genetic Testing Molecular genetic testing is a crucial step in diagnosing X-linked dominant hypophosphatemic rickets. This involves:

  • Gene-targeted testing, such as single gene testing or multigene panel
  • Comprehensive genetic testing to identify mutations in the PHEX gene
  • Confirming the diagnosis through molecular genetic testing

Differential Diagnosis It's essential to consider differential diagnoses, including autosomal dominant and autosomal recessive hypophosphatemic rickets. These conditions share similar symptoms but have distinct genetic causes.

References

  1. Establishing a diagnosis in a proband with characteristic clinical, biochemical, and radiographic findings by MD Ruppe (2017) [1]
  2. Molecular genetic testing approaches can include a combination of gene-targeted testing and comprehensive genetic testing (2012) [2]
  3. Confirming the diagnosis through molecular genetic testing and considering differential diagnoses (2019) [3]

Note: The numbers in square brackets refer to the corresponding search results provided in the context.

Additional Diagnostic Tests

  • Clinical Evaluation
  • Molecular Genetic Testing
  • Biochemical Analysis

Treatment

Treatment Options for X-linked Dominant Hypophosphatemic Rickets

X-linked dominant hypophosphatemic rickets (XLHRD) is a rare genetic disorder that affects bone mineralization and density. The primary goal of treatment is to manage the condition, prevent complications, and improve quality of life.

  • Phosphate Supplementation: Neutral phosphate solution or tablets are commonly used to lower ionized calcium concentrations and promote bone growth [3].
  • Vitamin D Therapy: Active forms of vitamin D, such as alfacalcidol or calcitriol, are often combined with phosphate salts to improve rickets and growth potential [5].
  • Anti-FGF23 Antibody Treatment: This treatment is sometimes used for XLHRD patients, especially those with severe symptoms [6].

Important Considerations

  • The optimal dose of oral phosphate varies according to age and severity of phenotype, and there is no consensus on the best dosage [4].
  • Vitamin D therapy alone may not be effective in improving rickets, as seen in some cases where high doses produced no change in the rachitic state [7].

References

[1] Saraff V. (2020) - The objectives of XLH treatment include healing rickets, improving leg deformities and avoiding orthopaedic surgery, maximising growth potential...

[3] Treatment of hypophosphatemic rickets consists of neutral phosphate solution or tablets.

[4] Haffner D. (2019) - Treatment doses vary according to age and severity of phenotype, and no consensus exists on the optimal dose of oral phosphate.

[5] Tajima T. (2022) - The conventional therapy consisting of phosphorus supplementation and alfacalcidol or calcitriol is effective for improving rickets and growth...

[6] Ackah SA. (2023) - The treatment depends on the underlying cause, but often includes active forms of vitamin D combined with phosphate salts, or anti-FGF23 antibody treatment...

Note: The above information is based on a summary of search results provided in the context.

Recommended Medications

  • Neutral phosphate solution or tablets
  • Active forms of vitamin D (alfacalcidol or calcitriol)
  • Anti-FGF23 antibody treatment

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Understanding Differential Diagnosis

When it comes to diagnosing complex medical conditions like X-linked dominant hypophosphatemic rickets, a differential diagnosis is essential to rule out other possible causes and arrive at an accurate conclusion. Here's what you need to know:

  • X-linked dominant hypophosphatemic rickets: This rare genetic disorder affects phosphate regulation in the body, leading to softening of bones (osteomalacia) or weakened bones (rachitic rosary) in children.
  • Differential diagnosis: A process of considering and eliminating other possible causes of a condition, based on symptoms, medical history, and test results.

Possible Causes to Consider

When diagnosing X-linked dominant hypophosphatemic rickets, the following conditions should be considered as part of the differential diagnosis:

  • Vitamin D deficiency: Insufficient vitamin D can lead to softening of bones (osteomalacia) or weakened bones (rachitic rosary).
  • Phosphate-wasting disorders: Other genetic conditions that affect phosphate regulation in the body, such as X-linked hypophosphatemia.
  • Other bone diseases: Conditions like osteogenesis imperfecta, which can cause fragile bones and other symptoms similar to X-linked dominant hypophosphatemic rickets.

Key Diagnostic Features

To differentiate X-linked dominant hypophosphatemic rickets from other conditions, the following features should be considered:

  • Genetic testing: A genetic test can confirm the presence of the PHEX gene mutation associated with X-linked dominant hypophosphatemic rickets.
  • Biochemical tests: Blood and urine tests can help identify abnormalities in phosphate regulation and rule out other causes of bone disease.
  • Imaging studies: Radiographs (x-rays) or other imaging techniques can show characteristic features of the condition, such as softening of bones or weakened bones.

References

  1. [12] - Differential has multiple meanings in mathematics, science, technology, social sciences, medicine and other fields. Learn about the different types and uses of differential, such as in calculus, geometry, mechanics, cryptography, diagnosis and more.
  2. [13] - Learn the definition, history and usage of the differential of a function in calculus. The differential is the principal part of the change in a function with respect to changes in the independent variable, and can be defined in various ways depending on the context and level of rigor.
  3. [14] - differential, in mathematics, an expression based on the derivative of a function, useful for approximating certain values of the function.

Note: The above response is based on general medical knowledge and should not be considered as professional medical advice. If you or someone you know has been diagnosed with X-linked dominant hypophosphatemic rickets, consult a qualified healthcare professional for personalized guidance and care.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_492
owl#annotatedSource
t332099
oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:0050445
core#notation
DOID:0050445
oboInOwl#hasDbXref
UMLS_CUI:C3540852
oboInOwl#hasExactSynonym
X-linked hypophosphatemia
rdf-schema#label
X-linked dominant hypophosphatemic rickets
IAO_0000115
A rickets has_material_basis_in X-linked mutations in the PHEX gene that lead to increased circulating levels of FGF-23, a phosphate-regulating hormone (phosphatonin), that leads to reduced renal phosphate reabsorption and consequently abnormal bone mineralization.
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t332651
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000146
relatedICD
http://example.org/icd10/Q96.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.